The Role of Business Development in Changing Global Times Thursday 28th & Friday 29th September 2017 Event Highlights • Welcome Networking Reception • NEW Partnering System to Arrange Your Own Private Meeting Schedule • Specific Private Meeting Area • 6 Presentation Sessions, including OTC, Digital Technology and IP & Market Access • Networking Reception and Gala Dinner at Casino de Madrid • Access to Copies of Authorised Presentation Post-Event • Opportunity to Network with BD Colleagues from Across Europe www.plg-group.com MADRID XIII International Pharma Licensing Symposium
5
Embed
XIII International Pharma Licensing Symposium - PLG · UK View - Jo Pisani, Partner, UK Pharma and ... This presentation will address how companies are looking at ... Email [email protected]
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
The Role of Business Development in Changing Global TimesThursday 28th & Friday 29th September 2017
Event Highlights
• Welcome Networking Reception
• NEW Partnering System to Arrange Your Own Private Meeting Schedule
• Specific Private Meeting Area
• 6 Presentation Sessions, including OTC, Digital Technology and IP & Market Access
• Networking Reception and Gala Dinner at Casino de Madrid
• Access to Copies of Authorised Presentation Post-Event
• Opportunity to Network with BD Colleagues from Across Europe
www.plg-group.comMADRID
XIII International PharmaLicensing Symposium
XIII IPLS, Madrid 27th - 29th September 2017
‘The Role of Business Development in Changing Global Times’
Proposed Programme
www.plg-group.com
Wednesday, 27th September
15.00 - 18.00 Pre-Arranged One-to-One Meetings
18.00 - 19.30 Welcome Drinks Reception
Thursday, 28th September
09.00 - 09.30 Registration
SESSION 1 External Factors Impacting the Pharmaceutical Industry
09.30 - 09.45
Introduction & Keynote Presentation Juan López-Belmonte, Vice President, Farmaindustria & CEO, Laboratorios Rovi Speaking from both an industry and business perspective, Juan López-Belmonte will be setting the scene identifying the key challenges emerging from the current political climate, with a focus on the economic and business implications for pharmaceutical deal making
09.45 - 10.15
Industry Drivers, Trends, Analysis and Forecasts Evaluate Sharing their insightful data and industry analysis, Evaluate are back by popular demand to identify the key trends evident in deals quantifying the impact on pharma business from the changing macro deal conditions
10.15 - 11.00
Brexit - Impact on Pharmaceutical Industry? European View: Impact on Strategies & UK View: Situation Post Brexit European View - Sergio Napolitano, Legal, Trade and Public Affairs Director, Medicines for Europe UK View - Jo Pisani, Partner, UK Pharma and Lifesciences Consulting Leader, PwC Strategy& Capturing and reflecting on the latest in developments in the Brexit negotiations, our speakers will comment on the key issues from both sides in the negotiation providing the view from the European and UK perspectives
11.00 - 11.30 Break
SESSION 2 The Impact of Digital Technology
11.30 - 12.00
Case Study – Sanofi & Voluntis Pierre Leurent, Voluntis In March Sanofi and Voluntis announced the original 2011 alliance to provide an app for assessing basal insulin was expanded. Pierre Leurent will be commenting on key features of this successful deal
12.00 - 12.30
Technology Companies Stepping into Digital Technologies Néstor Sanchez, Digital Transformation Manager, Indra With a wealth of experience in the development of healthcare information systems, Indra will review the impact of the transformations offered by digital technologies
12.30 - 13.00
Big Pharma Experience of Digital Technologies and Impact on Strategies Speaker TBC This presentation will address how companies are looking at integrating digital technologies into the company portfolio including the pitfalls and challenges that attend these new opportunities
XIII IPLS, Madrid 27th - 29th September 2017
‘The Role of Business Development in Changing Global Times’
Proposed Programme
www.plg-group.com
13.00 - 14.00 Lunch
SESSION 3 The Role of Business Development
14.00 - 16.00
Panel Discussion - Interaction between Alliance Management & Business Development Chair – Anthony Hörning, Strategic Transactions Advisory A discussion and debate on the adoption by companies of Good Partnering Practices – or do we as businesses simply pay lip service to the ethics of being a Partner of Choice?
16.00 - 17.30 Pre-Arranged One-to-One meetings
19.00 - 22.30 Gala Dinner
XIII IPLS, Madrid 27th - 29th September 2017
‘The Role of Business Development in Changing Global Times’
Proposed Programme
www.plg-group.com
Friday, 29th September
SESSION 4 The Increasing Importance of the OTC and Other Business Areas
09.00 - 09.30
Prescription to OTC Switching Speaker TBC This presentation will address the opportunities, and pitfalls, presented from OTC switching, including a review of recent switches
09.30 - 10.00 Bridging the Gap Between Pharma and FMCG Speaker TBC Identifying new business opportunities for growth in consumer healthcare markets
10.00 - 10.30
Emerging Trends in OTC & Why Big Pharma Should Play There Nicholas Hall, Chairman & CEO, Nicholas Hall Group of Companies Nicholas Hall will focus on the key opportunities arising in the OTC arena and the role major pharma play
10.30 - 11.00 Break
SESSION 5 Risk or Opportunity? IP & Market Access
11.00 - 11.30 IP Management/Protection Livia Villa, European Patent Attorney, ADVIP Livia Villa will review the latest developments in IP in Europe including updates on SPC’s
11.30 - 12.00
Market Access – European Trends Professor Mondher Toumi, CEO, Creativ-Ceutical Critical to successful BD, Professor Toumi will consider recent decisions and issues arising in securing prices and gaining effective market access in Europe
12.00 - 12.30 Break
SESSION 6 Financial Evaluation & Business Models
12.30 - 13.00 From Valuation to Assets or From Assets to Valuation? Zaki Sellam, Managing Director, ESN Life Sciences This session will address the key points in the valuation process
13.00 - 13.30
Business Models Speaker TBC With business deals becoming increasingly creative, this presentation will review some successful example of innovative deal structures
13.30 Lunch and close
XIII International Pharma Licensing Symposium
NH Collection Eurobuilding Hotel, Madrid Thursday 28th & Friday 29th September 2017
To register for the XIII IPLS Meeting, please complete this form and return to NGA using one of the following methods:
Post NGA, Millennia House, Kingswood Park, Bonsor Drive, Kingswood, Surrey, KT20 6AY, UK Email [email protected] Fax 00 44 (0)1737 379 802
Title Dr / Mr / Mrs / Ms Name
Job Title
Company
Address
Country
Telephone
Email (general contact and confirmation)
Email (used for delegate contact system)
Special Requirements (e.g. dietary, access requirements etc)
VAT Number (must be completed to confirm registration)
Price €875 Early Payment Discount Rate for payments received by 8th
May 2017
€1,025 Standard Rate for payments received on or after 9th
May 2017
Accommodation
Link to Discounted Accommodation Rates at NH Collection Eurobuilding Hotel, Madrid
Payment Payment by Cheque made payable to ‘NGA Ltd’ at the address above
Payment by Bank Transfer details will be sent out with booking confirmation
Payment by Credit Card MasterCard or Visa only, complete section below
Name of Card Holder
Credit Card Number
Expiry Date Security Code
Cardholder Signature Date
The NEW partnering system will be opened at the beginning of June, at which time you will be emailed a password to allow you access to your own profile on the partnering system, allowing you to edit your profile and arrange your own meeting schedule
Booking Terms & Conditions
Fee The attendance fee includes attendance at all sessions noted on the programme, all breaks, lunches and networking events. Please note that for reasons beyond the control of the organising committee it may prove necessary to change or amend the content or timing of the programme without prior warning. Meeting Registration – No Shows If having received a confirmed booking to the meeting, individuals who do not attend the meeting without prior notification to NGA in writing, will be liable for the full registration fee.
Meeting Cancellations Upon receiving your completed registration form, NGA will issue confirmation details and this booking will then be formally confirmed. Please note that all cancellations will be subject to a €50 administration charge. Delegate substitutions are welcome at any time. Cancellations received in writing after 21
st July 2017 will be subject to
100% cancellation charge unless the place can be re-sold to another delegate. In this case the €50 administration charge will apply. All cancellations must be sent to NGA in writing.